Cohance Lifesciences (formerly Suven Pharma) is the culmination of a deliberate series of mergers and acquisitions — including ZCL Chemicals, Avra Laboratories, Suven Pharma, Sapala Organics, and NJ Bio — bringing together the differentiated capabilities of a pharma CDMO across APIs, specialty chemicals, formulations, and next-generation platforms such as ADCs and oligonucleotides. The result is an integrated, technology-driven global CDMO with state-of-the-art facilities across India and the U.S.